Beta blockers may increase survival rates of melanoma patients
Patients with metastatic melanoma, or melanoma that has spread to other parts of the body, often have a poor prognosis, and while some forms of immunotherapy -- treatments that boost the body's immune system to fight disease -- are promising, response rates are less than 35 per cent.
Jan 10, 2018, 16:11 PM IST